Are you need IT Support Engineer? Free Consultant
FOR IMMEDIATE RELEASE Contact: Meliza Anne Mitra [email protected] Sproxil Announces Alliance with Greenlife Pharmaceutical Limited and Bliss GVS Pharma Limited to Protect LONART DS From Counterfeiting First Cross-National Collaboration
Sproxil is pleased to welcome Paul W. Chang to our Board of Advisors. Our official announcement is here. Paul is the Global Business Strategy Lead, Emerging Technologies for IBM Software
Government-mandated item-unique serialization initiatives continue to face challenges from pharmaceutical firms in developing economies. Below is an interesting piece on challenges with government mandates on serialization, with views from Indian
Investment Will Help Sproxil Build Sales Teams, Expand into India and Kenya, and Make Improvements to the TechnologyNew York, NY (PRWEB) March 22, 2011 Acumen Fund, a nonprofit global venture
The recent three-day recent Accelerate Michigan Innovation Competition showcased promise and opportunities for emerging companies across the technology, medical device, manufacturing, and life sciences fields to name a few. Several
After a fantastic week in Ireland, we are glad to announce that we received one of the two honorable mentions at IBM’s Global SmartCamp finals. IBM’s corporate strategy to identify
Last quarter ended with great progress on expanding our efforts across Africa while receiving praise for the milestones Sproxil and its collaborators have already achieved.The momentum has rolled into this
Sproxil, Inc. is a privately backed company that provides comprehensive anti-counterfeiting strategies for cash-based societies, including solutions for drug and product verification. Sproxil’s business model has caused it to make
We have had a tremendous month at Sproxil. We’ve hit some major authentication volume milestones and just this week made two major announcements. Like Pfizer, Vodafone and WaterHealth, we made
Former CBS Evening News anchor Dan Rather makes a trip to Nigeria after investigating the mysterious case of Kevin Xu, a convicted counterfeiter who had a wide array of prescription